Project CARE: CAncer Risk Evaluation

Recruiting now · Not applicable

Conditions studied: Primary Care

In brief

The purpose of Project CARE (cancer risk assessment and evaluation) research study is to explore the acceptance and feasibility of a study-initiated proactive outreach and digital care delivery model for conducting hereditary cancer risk assessment in primary care settings and facilitating genetic risk evaluation for patients flagged as high risk. Potential participants will be recruited from Rutgers Health primary care sites (family practice and general internal medicine). EPIC will be used to identify all potential participants and they will be invited to participate in the study. Consented participants will be provided a link via email, and or text message to engage with a Relational Agent (RA, chatbot), through the patient portal for cancer risk assessment and genetic education. Those identified as high risk will be offered genetic counseling and testing. The research questions the study aims to answer are: 1. What percent of patients who completed the RA are identified as high risk? 2. What percent of patients who engaged with the risk assessment were identified as high risk? 3. What percent of high-risk patients had genetic counseling or genetic testing within 4 months of completing the risk assessment?

Key facts

Study ID

NCT07130487

Run by

Anita Y. Kinney, PhD, RN

People needed

210

Starts

2025-11-19

Expected to finish

2026-11-01

Last updated by the study team

2025-11-25

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 to 70 years
• Able to read and speak English
• Have an email address or mobile phone number in EPIC and/or are enrolled in MyChart
• Receiving health care in Family Medicine or General Internal Medicine at Rutgers Health within the past 2 years
• Have not opted out of receiving research-related communications
• Have internet access (via smartphone, tablet, or computer)

You may not qualify if…

• Dementia (e.g., Alzheimer's disease) as indicated in EPIC
• Unable to access the Internet (via smartphone, tablet, or computer)
• Previous germline genetic testing for hereditary cancer risk
• Opted out of research participation in EPIC
• Have a personal history of cancer

Where it is running

• Rutgers, The State University of New Jersey — New Brunswick, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.